Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTCMKTS · Delayed Price · Currency is USD
4.400
0.00 (0.00%)
Aug 15, 2025, 4:00 PM EDT
HNSPF Market Cap
HNSPF has a market cap or net worth of $28.35 billion as of August 15, 2025. Its market cap has increased by 124.86% in one year.
Market Cap
28.35B
Enterprise Value
25.18B
Revenue
1.68B
Ranking
n/a
PE Ratio
47.33
Stock Price
$4.40
Market Cap Chart
Since June 14, 2019, HNSPF's market cap has increased from 14.22B to 28.35B, an increase of 99.39%. That is a compound annual growth rate of 11.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 28.35B | 114.71% |
| Dec 31, 2024 | 13.20B | 10.47% |
| Dec 29, 2023 | 11.95B | 6.05% |
| Dec 30, 2022 | 11.27B | -21.91% |
| Dec 31, 2021 | 14.43B | -49.73% |
| Dec 31, 2020 | 28.70B | 49.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 598.01M |
| Elite Pharmaceuticals | 567.50M |
| Nika Pharmaceuticals | 360.27M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 325.38M |